Reprogramming Mycobacterium tuberculosis CRISPR System for Gene Editing and Genome-wide RNA Interference Screening

Reprogramming Mycobacterium tuberculosis CRISPR System for Gene Editing and Genome-wide RNA Interference Screening

Mycobacterium tuberculosis is the causative agent of tuberculosis (TB), which is still the leading cause of mortality from a single infectious disease worldwide. The development of novel anti-TB drugs and vaccines is severely hampered by the complicated and time-consuming genetic manipulation techni...

Full description

Bibliographic Details
Main Authors:	Khaista Rahman, Muhammad Jamal, Xi Chen, Wei Zhou, Bin Yang, Yanyan Zou, Weize Xu, Yingying Lei, Chengchao Wu, Xiaojian Cao, Rohit Tyagi, Muhammad Ahsan Naeem, Da Lin, Zeshan Habib, Nan Peng, Zhen F. Fu, Gang Cao
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Genomics, Proteomics & Bioinformatics
Subjects:	Mycobacterium tuberculosis Type III-A CRISPR system Gene editing Gene interference Genome-wide RNAi screening
Online Access:	http://www.sciencedirect.com/science/article/pii/S1672022921002497

Similar Items

CRISPR Interference–Potential Application in Retinal Disease
by: Caroline F. Peddle, et al.
Published: (2020-03-01)

Editorial: Frontiers in global regulatory landscape of CRISPR-edited plants
by: Aftab Ahmad, et al.
Published: (2024-01-01)

Type I CRISPR-Cas-mediated microbial gene editing and regulation
by: Zeling Xu, et al.
Published: (2023-12-01)

CRISPR‐Cas13d effectively targets SARS‐CoV‐2 variants, including Delta and Omicron, and inhibits viral infection
by: Zongzhi Liu, et al.
Published: (2023-02-01)

Validation of gene editing efficiency with CRISPR-Cas9 system directly in rat zygotes using electroporation mediated delivery and embryo culture
by: Anil K. Challa, et al.
Published: (2021-01-01)

Reprogramming the endogenous type I CRISPR‐Cas system for simultaneous gene regulation and editing in Haloarcula hispanica
by: Kaixin Du, et al.
Published: (2022-03-01)

The enhancement of CRISPR/Cas9 gene editing using metformin
by: Jaedyn L. Rollins, et al.
Published: (2023-09-01)

Demystification and feasibility of CRISPR technology and gene editing in African laboratories
by: Mohamed Jemaà
Published: (2023-10-01)

Various Aspects of a Gene Editing System—CRISPR–Cas9
by: Edyta Janik, et al.
Published: (2020-12-01)

Application Progress of CRISPR/Cas9 System for Gene Editing in Tumor Research
by: Chao LIU, et al.
Published: (2015-09-01)

CRISPR/Cas9 Genome-Editing Technology and Potential Clinical Application in Gastric Cancer
by: Renata Sanches Almeida, et al.
Published: (2022-11-01)

Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening
by: Ning Sun, et al.
Published: (2019-03-01)

A homology independent sequence replacement strategy in human cells using a CRISPR nuclease
by: Eric Danner, et al.
Published: (2021-01-01)

Advances and Prospects of Virus-Resistant Breeding in Tomatoes
by: Zolfaghar Shahriari, et al.
Published: (2023-10-01)

Cell Line Techniques and Gene Editing Tools for Antibody Production: A Review
by: Arun K. Dangi, et al.
Published: (2018-06-01)

Editorial: CRISPR advancement in cancer research and future perspectives
by: Alessio Biagioni, et al.
Published: (2023-03-01)

Editorial: CRISPR and beyond: Cutting-edge technologies for gene correction in therapeutic applications
by: Ayal Hendel, et al.
Published: (2023-04-01)

CRISPR Technology: A Jewish Legal Perspective
by: John D. Loike, et al.
Published: (2022-10-01)

The CRISPR/Cas system: Gene Editing by bacterial defense
by: Amira H. El-Ashry
Published: (2023-09-01)

Editorial: CRISPR-Cas Systems in Bacteria and Archaea
by: Muhammad Kamruzzaman, et al.
Published: (2022-03-01)

Harnessing the Potential of CRISPR/Cas in Atherosclerosis: Disease Modeling and Therapeutic Applications
by: Wei Sheng Siew, et al.
Published: (2021-08-01)

Gene editing and therapy – A new tool: CRISPR/Cas9
by: Ashok M. Patil
Published: (2019-07-01)

Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications
by: Lifang Zhou, et al.
Published: (2023-04-01)

How has CRISPR transformed therapeutic drug discovery?
by: Jade Parker
Published: (2023-03-01)

Transgenesis in parasitic helminths: a brief history and prospects for the future
by: M. J. Quinzo, et al.
Published: (2022-03-01)

CRISPR Cpf1 proteins: structure, function and implications for genome editing
by: Fatemeh Safari, et al.
Published: (2019-05-01)

CRISPR/Cas9-gene editing approaches in plant breeding
by: Himanshu Saini, et al.
Published: (2023-12-01)

CRISPR/Cas patents and health-related publications in South America
by: LARIANE FRÂNCIO, et al.
Published: (2023-06-01)

CRISPR/CAS9 SYSTEM : APPLICATIONS AND TECHNOLOGY /
by: Bertelsen, Alfred A., editor
Published: (2019)

In Our Image: The Ethics of CRISPR Genome Editing
by: Eissenberg Joel C.
Published: (2021-02-01)

CRISPR/Cas9 Application for Gene Copy Fate Survey of Polyploid Vertebrates
by: Fanqian Yin, et al.
Published: (2018-07-01)

New Therapeutics for Extracellular Vesicles: Delivering CRISPR for Cancer Treatment
by: Biying Yan, et al.
Published: (2022-12-01)

CRISPR/Cas systems usher in a new era of disease treatment and diagnosis
by: Ruiting Li, et al.
Published: (2022-10-01)

Mutant allele knockout with novel CRISPR nuclease promotes myelopoiesis in ELANE neutropenia
by: Peter Sabo, et al.
Published: (2022-09-01)

Tagging to endogenous genes of Plasmodium falciparum using CRISPR/Cas9
by: Dexuan Kuang, et al.
Published: (2017-12-01)

Editorial: Regulation and governance of gene editing technologies (CRISPR, etc.)
by: Alberto Asquer, et al.
Published: (2022-09-01)

CRISPR delivery with extracellular vesicles: Promises and challenges
by: Anne Højberg Berggreen, et al.
Published: (2023-09-01)

Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy
by: Mohammed Fatih Rasul, et al.
Published: (2022-03-01)

Gene Editing Profiles in 94 CRISPR-Cas9 Expressing T<sub>0</sub> Transgenic Tobacco Lines Reveal High Frequencies of Chimeric Editing of the Target Gene
by: Guo-Qing Song, et al.
Published: (2022-12-01)

Generation of HLA Universal Megakaryocytes and Platelets by Genetic Engineering
by: Constanca Figueiredo, et al.
Published: (2021-10-01)